1,299
Views
37
CrossRef citations to date
0
Altmetric
Reviews

Toxicity and applications of surfactin for health and environmental biotechnology

, &

References

  • Abdel-Mawgoud, A. M., M. M. Aboulwafa, and N. A. Hassouna. 2008. Characterization of surfactin produced by Bacillus subtilis isolate BS5. Appl. Biochem. Biotechnol. 15:289–303. doi:10.1007/s12010-008-8153-z.
  • Al-Wahaibi, Y., S. Joshi, S. Al-Bahry, A. Elshafie, A. Al-Bemani, and B. Shibulal. 2014. Biosurfactant production by Bacillus subtilis B30 and its application in enhancing oil recovery. Colloids Surf. B Biointerfaces 114:324–33. doi:10.1016/j.colsurfb.2013.09.022.
  • Arima, K., A. Kakinuma, and G. Tamura. 1968. Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: Isolation, characterization and its inhibition of fibrin clot formation. Biochem. Biophys. Res. Commun. 31:488–94. doi:10.1016/0006-291X(68)90503-2.
  • Banat, I. M., S. K. Satpute, S. S. Cameotra, R. Patil, and N. V. Nyayanit. 2014. Cost effective technologies and renewable substrates for biosurfactants’ production. Front. Microbiol. 5:697. doi:10.3389/fmicb.2014.00697.
  • Blanchard, A., and L. Montagnier. 1994. Aids-associated mycoplasmas. Annu. Rev. Microbiol. 48:687–712. doi:10.1146/annurev.mi.48.100194.003351.
  • Bonmatin, J. M., M. Genest, H. Labbé, and M. Ptak. 1994. Solution three-dimensional structure of surfactin: A cyclic lipopeptide studied by 1H-nmr, distance geometry, and molecular dynamics. Biopolymers 34:975–86. doi:10.1002/bip.360340716.
  • Bonmatin, J. M., O. Laprevote, and F. Peypoux. 2003. Diversity among microbial cyclic lipopeptides: Iturins and surfactins. Activity-structure relationships to design new bioactive agents. Comb. Chem. High Throughput Screen. 6:541–56. doi:10.2174/138620703106298716.
  • Brown, L. R. 2010. Microbial enhanced oil recovery (MEOR). Curr. Opin. Microbiol. 13:316–20. doi:10.1016/j.mib.2010.01.011.
  • Cao, X. H., A. H. Wang, C. L. Wang, D. Z. Mao, M. F. Lu, Y. Q. Cui, and R. Z. Jiao. 2010. Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway. Chem. Biol. Interact. 183:357–62. doi:10.1016/j.cbi.2009.11.027.
  • Cao, X. H., A. H. Wang, R. Z. Jiao, C. L. Wang, D. Z. Mao, L. Yan, and B. Zeng. 2009b. Surfactin induces apoptosis and G(2)/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation. Cell Biochem. Biophys. 55:163–71. doi:10.1007/s12013-009-9065-4.
  • Cao, X. H., Z. Y. Liao, C. L. Wang, W. Y. Yang, and M. F. Lu. 2009a. Evaluation of a lipopeptide biosurfactant from Bacillus natto TK-1 as a potential source of anti-adhesive, antimicrobial and antitumor activities. Braz. J. Microbiol. 40:373–79. doi:10.1590/S1517-83822009000200030.
  • Carrillo, C., J. A. Teruel, F. J. Aranda, and A. Ortiz. 2003. Molecular mechanism of membrane permeabilization by the peptide antibiotic surfactin. Biochim. Biophys. Acta Biomembr. 1611:91–97. doi:10.1016/S0005-2736(03)00029-4.
  • Chen, W. C., R. S. Juang, and Y. H. Wei. 2015. Applications of a lipopeptide biosurfactant, surfactin, produced by microorganisms. Biochem. Eng. J. 103:158–69. doi:10.1016/j.bej.2015.07.009.
  • Chooi, Y. H., and Y. Tang. 2010. Adding the lipo to lipopeptides: Do more with less. Chem. Biol. 17:791–93. doi:10.1016/j.chembiol.2010.08.001.
  • Cimolai, N. 2001. Do mycoplasmas cause human cancer? Can. J. Microbiol. 47:691–97. doi:10.1139/cjm-47-8-691.
  • Curran, S., and G. I. Murray. 1999. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 189:300–08. doi:10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C.
  • Day, J. G., Y. Gong, and Q. Hu. 2017. Microzooplanktonic grazers – A potentially devastating threat to the commercial success of microalgal mass culture. Algal Res. 27:356–65. doi:10.1016/j.algal.2017.08.024.
  • De França, I. W. L., A. P. Lima, J. A. M. Lemos, C. G. F. Lemos, V. M. M. Melo, H. B. de Sant’ana, and L. R. B. Gonçalves. 2015. Production of a biosurfactant by Bacillus subtilis ICA56 aiming bioremediation of impacted soils. Catal. Today 255:10–15. doi:10.1016/j.cattod.2015.01.046.
  • De Oliveira, D. W. F., A. B. Cara, M. Lechuga-Villena, M. García-Román, V. M. N. Melo, L. R. B. Gonçalves, and D. A. Vaz. 2017. Aquatic toxicity and biodegradability of a surfactant produced by Bacillus subtilis ICA56. J. Environ. Sci. Health A 52:174–81. doi:10.1080/10934529.2016.1240491.
  • Dehghan-Noudeh, G., M. R. Housaindokht, and B. S. F. Bazzaz. 2005. Isolation, characterization, and investigation of surface and hemolytic activities of a lipopeptide biosurfactant produced by Bacillus subtilis ATCC 6633. J. Microbiol. 43:272–76.
  • Deravel, J., S. Lemiere, F. Coutte, F. Krier, N. Van Hese, M. Béchet, N. Sordeau, M. Hofte, A. Leprêtre, and P. Jacques. 2014. Mycosubtilin and surfactin are efficient, low ecotoxicity molecules for the biocontrol of lettuce downy mildew. Appl. Microbiol. Biotechnol. 98:6255–64. doi:10.1007/s00253-014-5663-1.
  • Dorn, P. B., J. P. Salanitro, S. H. Evans, and L. Kravetz. 1993. Assessing the aquatic hazard of some branched and linear nonionic surfactants by biodegradation and toxicity. Environ. Toxicol. Chem. 12:1751–62. doi:10.1002/etc.5620121002.
  • Duarte, C., E. J. Gudiña, C. F. Lima, and L. R. Rodrigues. 2014. Effects of biosurfactants on the viability and proliferation of human breast cancer cells. AMB Express 4:40. doi:10.1186/s13568-014-0040-0.
  • Dufour, S., M. Deleu, K. Nott, B. Wathelet, P. Thonart, and M. Paquot. 2005. Hemolytic activity of new linear surfactin analogs in relation to their physico-chemical properties. Biochim. Biophys. Acta 1725:87–95. doi:10.1016/j.bbagen.2005.06.015.
  • Feng, S. H., S. Tsai, J. Rodriguez, and S. C. Lo. 1999. Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol. Cell. Biol. 19:7995–8002. doi:10.1128/MCB.19.12.7995.
  • Gao, Z., X. Zhao, S. Lee, J. Li, H. Liao, X. Zhou, J. Wu, and G. Qi. 2013. WH1fungin a surfactin cyclic lipopeptide is a novel oral immunoadjuvant. Vaccine 31:2796–803. doi:10.1016/j.vaccine.2013.04.028.
  • Geetha, I., and A. M. Manonmani. 2010. Surfactin: A novel mosquitocidal biosurfactant produced by Bacillus subtilis ssp. subtilis (VCRC B471) and influence of abiotic factors on its pupicidal efficacy. Lett. Appl. Microbiol. 51:406–12. doi:10.1111/j.1472-765X.2010.02912.x.
  • Geetha, I., G. Prabakaran, K. P. Paily, A. M. Manonmani, and K. Balaraman. 2007. Characterisation of three mosquitocidal Bacillus strains isolated from mangrove forest. Biol. Control 42:34–40. doi:10.1016/j.biocontrol.2007.04.003.
  • Ghiselli, R., A. Giacometti, O. Cirioni, R. Circo, F. Mocchegiani, B. Skerlavaj, G. D’amato, G. Scalise, M. Zanetti, and V. Saba. 2003. Neutralization of endotoxin in vitro and in vivo by Bac7 (1–35),a proline-rich antibacterial peptide. Shock 19:577–81. doi:10.1097/01.shk.0000055236.26446.c9.
  • Gomes, M. Z. V., and M. Nitschke. 2012. Evaluation of rhamnolipid and surfactin to reduce the adhesion and remove biofilms of individual and mixed cultures of food pathogenic bacteria. Food Control 25:441–47. doi:10.1016/j.foodcont.2011.11.025.
  • Grau, A., J. C. G. Fernández, F. Peypoux, and A. Ortiz. 1999. A study on the interactions of surfactin with phospholipid vesicles. Biochim. Biophys. Acta Biomembr. 1418:307–19. doi:10.1016/S0005-2736(99)00039-5.
  • Gudiña, E. J., J. A. Teixeira, and L. R. Rodrigues. 2016. Biosurfactants produced by marine microorganisms with therapeutic applications. Mar. Drugs 14. doi:10.3390/md14020038.
  • Heerklotz, H., and J. Seelig. 2001. Detergent-like action of the antibiotic peptide surfactin on lipid membranes. Biophys. J. 81:1547–54. doi:10.1016/S0006-3495(01)75808-0.
  • Heerklotz, H., and J. Seelig. 2007. Leakage and lysis of lipid membranes induced by the lipopeptide surfactin. Eur. Biophys. J. 36:305–14. doi:10.1007/s00249-006-0091-5.
  • Hickey, C. W., C. Blaise, and G. Costan. 1991. Microtesting appraisal of ATP and cell recovery toxicity end points after acute exposure of Selenastrum capricornutum to selected chemicals. Environ. Toxicol. Water Qual. 6:383–403. doi:10.1002/tox.2530060404.
  • Hodges, G., D. W. Roberts, S. J. Marshall, and J. C. Dearden. 2006. The aquatic toxicity of anionic surfactants to Daphnia magna – A comparative QSAR study of linear alkylbenzene sulphonates and ester sulphonates. Chemosphere 63:1443–50. doi:10.1016/j.chemosphere.2005.10.001.
  • Huang, W., Y. Lang, A. Hakeem, Y. Lei, L. Gan, and X. Yang. 2018. Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers. Int. J. Nanomed. 13:1723–36. doi:10.2147/IJN.S157368.
  • Hubbard, M., R. K. Hynes, M. Erlandson, and K. L. Bailey. 2014. The biochemistry behind biopesticide efficacy. Sustainable Chem. Processes 2:18. doi:10.1186/s40508-014-0018-x.
  • Hwang, Y. H., B. K. Park, J. H. Lim, M. S. Kim, I. B. Song, S. C. Park, and H. I. Yun. 2008. Evaluation of genetic and developmental toxicity of surfactin C from Bacillus subtilis BC1212. J. Health Sci. 54764:101–06. doi:10.1248/jhs.54.101.
  • Hwang, Y. H., B. K. Park, J. H. Lim, M. S. Kim, S. C. Park, M. H. Hwang, and H. I. Yun. 2007. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock. Eur. J. Pharmacol. 556:166–71. doi:10.1016/j.ejphar.2006.10.031.
  • Hwang, Y. H., M. S. Kim, I. B. Song, B. K. Park, J. H. Lim, S. C. Park, and H. I. Yun. 2009. Subacute (28 day) toxicity of surfactin c, a lipopeptide produced by Bacillus subtilis, in rats. J. Health Sci. 55:351–55. doi:10.1248/jhs.55.351.
  • Inés, M., and G. Dhouha. 2015. Lipopeptide surfactants: Production, recovery and pore forming capacity. Peptides 71:100–12. doi:10.1016/j.peptides.2015.07.006.
  • Ishigami, Y., M. Osman, H. Nakahara, Y. Sano, R. Ishiguro, and M. Matsumoto. 1995. Significance of β-sheet formation for micellization and surface adsorption of surfactin. Colloids Surf. B Biointerfaces 4:341–48. doi:10.1016/0927-7765(94)01183-6.
  • Jackson, M., C. Eadsforth, D. Schowanek, T. Delfosse, A. Riddle, and N. Budgen. 2016. Comprehensive review of several surfactants in marine environments: Fate and ecotoxicity. Environ. Toxicol. Chem. 35:1077–86. doi:10.1002/etc.3297.
  • Jiao, S., X. Li, H. Yu, H. Yang, X. Li, and Z. Shen. 2016. In situ enhancement of surfactin biosynthesis in Bacillus subtilis using novel artificial inducible promoters. Biotechnol. Bioeng. 114:832–42. doi:10.1002/bit.26197.
  • Jin, L., V. M. Garamus, F. Liu, J. Xiao, H. Eckerlebe, R. W. Römer, B. Mu, and A. Zou. 2016. Interaction of a biosurfactant, surfactin with a cationic gemini surfactant in aqueous solution. J. Colloid Interface Sci. 481:201–09. doi:10.1016/j.jcis.2016.07.044.
  • Jung, J., K. O. Yu, A. B. Ramzi, S. H. Choe, S. W. Kim, and S. O. Han. 2012. Improvement of surfactin production in Bacillus subtilis using synthetic wastewater by overexpression of specific extracellular signaling peptides, comX and phrC. Biotechnol. Bioeng. 109:2349–56. doi:10.1002/bit.24524.
  • Kakinuma, A., H. Sugino, M. Isono, G. Tamura, and K. Arima. 1969. Determination of fatty acid in surfactin and elucidation of the total structure of surfactin. Agric. Biol. Chem. 33:973–76. doi:10.1080/00021369.1969.10859409.
  • Kameda, Y., S. Ouhira, K. Matsui, S. Kanatomo, T. Hase, and T. Atsusaka. 1974. Antitumor activity of Bacillus natto. V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311. Chem. Pharm. Bull. 22:938–44. doi:10.1248/cpb.22.938.
  • Kang, D. S., C. H. Kwon, J. Y. Park, J. H. Kim, J. S. Woo, J. S. Jung, and K. Y. Kim. 2006. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism. Toxicol. Appl. Pharmacol. 216:426–35. doi:10.1016/j.taap.2006.06.008.
  • Kikuchi, T., and K. Hasumi. 2002. Enhancement of plasminogen activation by surfactin C: Augmentation of fibrinolysis in vitro and in vivo. Biochim. Biophys. Acta 1596:234–45. doi:10.1016/S0167-4838(02)00221-2.
  • Kim, K. M., J. Y. Lee, C. K. Kim, and J. S. Kang. 2009. Isolation and characterization of surfactin produced by Bacillus polyfermenticus KJS-2. Arch. Pharm. Res. 32:711–15. doi:10.1007/s12272-009-1509-2.
  • Kim, S. Y., J. Y. Kim, S. H. Kim, H. J. Bae, H. Yi, S. H. Yoon, B. S. Koo, M. Kwon, J. Y. Cho, C. E. Lee, et al. 2007. Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Lett. 58:865–71. doi:10.1016/j.febslet.2007.01.059.
  • Knoblich, A., M. Matsumoto, R. Ishiguro, K. Murata, Y. Fujiyoshi, Y. Ishigami, and M. Oman. 1995. Electron cryo-microscopic studies on micellar shape and size of surfactin, an anionic lipopeptide. Colloids Surf. B Biointerfaces 5:43–48. doi:10.1016/0927-7765(95)01207-Y.
  • Kowall, M., J. Vater, B. Kluge, T. Stein, P. Franke, and D. Ziessow. 1998. Separation and characterization of surfactin isoforms produced by Bacillus subtilis OKB 105. J. Colloid Interface Sci. 204:1–8.
  • Kracht, M., H. Rokos, M. Ozel, M. Kowall, G. Pauli, and J. Vater. 1999. Antiviral and haemolytic activities of surfactin isoforms and their methyl ester derivatives. J. Antibiot. 52:613–19.
  • Krishnan, N., B. Velramar, R. Pandiyan, and R. K. Velu. 2018. Anti-pseudomonal and anti-endotoxic effects of surfactin-stabilized biogenic silver nanocubes ameliorated wound repair in streptozotocin-induced diabetic mice. Artif. Cells Nanomed. Biotechnol. 46:488–99. doi:10.1080/21691401.2017.1324461.
  • Lai, C. C., Y. C. Huang, Y. H. Wei, and J. S. Chang. 2009. Biosurfactant-enhanced removal of total petroleum hydrocarbons from contaminated soil. J. Hazard. Mater. 167:609–14. doi:10.1016/j.jhazmat.2009.01.017.
  • Lee, J. H., S. H. Nam, W. T. Seo, H. D. Yun, S. Y. Hong, M. K. Kim, and K. M. Cho. 2012. The production of surfactin during the fermentation of cheonggukjang by potential probiotic Bacillus subtilis CSY191 and the resultant growth suppression of MCF-7 human breast cancer cells. Food Chem. 131:1347–54. doi:10.1016/j.foodchem.2011.09.133.
  • Li, P., A. Tan, C. A. Prestidge, H. M. Nielsen, and A. Mullertz. 2014. Self-nanoemulsifying drug delivery systems for oral insulin delivery: In vitro and in vivo evaluations of enteric coating and drug loading. Int. J. Pharm. 477:390–98. doi:10.1016/j.ijpharm.2014.10.039.
  • Li, X., H. Yang, D. Zhang, X. Li, H. Yu, and Z. Shen. 2015. Overexpression of specific proton motive force-dependent transporters facilitate the export of surfactin in Bacillus subtilis. J. Ind. Microbiol. Biotechnol. 42:93–103. doi:10.1007/s10295-014-1527-z.
  • Lima, T. M. S., L. C. Procópio, F. D. Brandão, B. A. Leão, M. R. Tótola, and A. C. Borges. 2011. Evaluation of bacterial surfactant toxicity towards petroleum degrading microorganisms. Bioresour. Technol. 102:2957–64. doi:10.1016/j.biortech.2010.09.109.
  • Liu, J. F., M. S. Mbadinga, S. Z. Yang, J. D. Gu, and B. Z. Mu. 2015. Chemical structure, property and potential applications of biosurfactants produced by Bacillus subtilis in petroleum recovery and spill mitigation. Int. J. Mol. Sci. 16:4814–37. doi:10.3390/ijms16034814.
  • Liu, X., X. Tao, A. Zou, S. Yang, L. Zhang, and B. Mu. 2010. Effect of the microbial lipopeptide on tumor cell lines: Apoptosis induced by disturbing the fatty acid composition of cell membrane. Protein Cell 1:584–94. doi:10.1007/s13238-010-0072-4.
  • Logunov, D. Y., D. V. Scheblyakov, O. V. Zubkova, M. M. Shmarov, I. V. Rakovskaya, K. V. Gurova, L. G. Burdelya, B. S. Naroditsky, A. L. Ginzburg, and A. V. Gudkov. 2008. Mycoplasma infection suppresses p53, activates NF-κB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene 27:4521–31. doi:10.1038/onc.2008.103.
  • Loiseau, C., M. Schlusselhuber, R. Bigot, J. Bertaux, J. M. Berjeaud, and J. Verdon. 2015. Surfactin from Bacillus subtilis displays an unexpected anti-Legionella activity. Appl. Microbiol. Biotechnol. 99:5083–93. doi:10.1007/s00253-014-6317-z.
  • Maget-Dana, R., and M. Ptak. 1995. Interactions of surfactin with membrane models. Biophys. J. 68:1937–43. doi:10.1016/S0006-3495(95)80370-X.
  • Makkar, R. S., and S. S. Cameotra. 1999. Structural characterization of a biosurfactant produced by Bacillus subtilis at 45℃. J. Surfactants Deterg. 2:367–72. doi:10.1007/s11743-999-0091-6.
  • Mansourpour, M., R. Mahjub, M. Amini, S. N. Ostad, E. S. Shamsa, M. R. Tehrani, and F. A. Dorkoosh. 2015. Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery. AAPS Pharm. Sci. Tech. 16:952–62. doi:10.1208/s12249-014-0282-9.
  • Meena, K. R., and S. S. Kanwar. 2015. Lipopeptides as the antifungal and antibacterial agents: Applications in food safety and therapeutics. Biomed. Res. Int. 2015:1–9. doi:10.1155/2015/473050.
  • Mitchell, C. A., C. Shi., C. C. Aldrich, and A. M. Gulick. 2012. Structure of PA1221, a nonribosomal peptide synthase containing adenylation and peptidyl carrier protein domains. Biochemistry 51:3252–63. doi:10.1021/bi300112e.
  • Mohammed, A. 2007. Comparative sensitivities of the tropical cladoceran, Ceriodaphnia rigaudii and the temperate species Daphnia magna to seven toxicants. Toxicol. Environ. Chem. 82:347–52. doi:10.1080/02772240601035888.
  • Moryl, M., M. Spetana, K. Dziobek, K. Paraszkiewicz, R. Rósalzka, G. A. Plaza, and A. Rósalzki. 2015. Antimicrobial, antiadhesive and antibiofilm potential of lipopeptides synthesised by Bacillus subtilis, on uropathogenic bacteria. Acta Biochim. Pol. 62:725–32. doi:10.18388/abp.2015_1120.
  • Mulligan, C. N. 2005. Environmental applications for biosurfactants. Environ. Pollut. 133:183–98. doi:10.1016/j.envpol.2004.06.009.
  • Mulligan, C. N., R. N. Yong, B. F. Gibbs, S. James, and H. P. J. Bennett. 1999. Metal removal from contaminated soil and sediments by the biosurfactant surfactin. Environ. Sci. Technol. 33:3812–20. doi:10.1021/es9813055.
  • Mungray, A. K., and P. Kumar. 2008. Occurrence of anionic surfactants in treated sewage: Risk assessment to aquatic environment. J. Hazard. Mater. 160:362–70. doi:10.1016/j.jhazmat.2008.03.025.
  • Myszka, K., and K. Czaczyk. 2011. Bacterial biofilms on food contact surfaces – A review. Pol. J. Food Nutr. Sci. 61:173–80. doi:10.2478/v10222-011-0018-4.
  • Nagai, S., K. Okimura, N. Kaizawa, K. Ohki, and S. Kanatomo. 1996. Study of surfactin, a depsipeptide. II. Synthesis of surfactin B2 produced by Bacillus natto KMD 2311. Chem. Pharm. Bull. 44:5–10. doi:10.1248/cpb.44.5.
  • Nakano, M. M., R. Magnuson, A. Myers, J. Curry, A. D. Grossman, and P. Zuber. 1991. srfA is an operon required for surfactin production, competence development, and efficient sporulation in Bacillus subtilis. J. Bacteriol. 173:1770. doi:10.1128/jb.173.5.1770-1778.1991.
  • Nozhat, Z., A. Asadi, and S. Zahri. 2012. Properties of surfactin c-15 nanopeptide and its cytotoxic effect on human cervix cancer (HeLa) cell line. J. Nanomater. 2012. doi:10.1155/2012/526580.
  • Paraszkiewicz, K., P. Bernat, A. Kuśmierska, J. Chojniak, and G. Płaza. 2018. Structural identification of lipopeptide biosurfactants produced by Bacillus subtilis strains grown on the media obtained from renewable natural resources. J. Environ. Manage. 209:65–70. doi:10.1016/j.jenvman.2017.12.033.
  • Park, S. Y., J. H. Kim, Y. J. Lee, and Y. Kim. 2013. Surfactin suppresses TPA-induced breast cancer cell invasion through inhibition of MMP-9 expression. Int. J. Oncol. 42:287–96. doi:10.3892/ijo.2012.
  • Peypoux, F., and G. Michel. 1992. Controlled biosynthesis of Val7- and Leu7-surfactins. Appl. Microbiol. Biotechnol. 36:515–17. doi:10.1007/BF00170194.
  • Peypoux, F., J. M. Bonmatin, H. Labbe, I. Grangemard, B. C. Das, M. Ptak, J. Wallach, and G. Michel. 1994. [Ala4]Surfactin, a novel isoform from bacillus subtilis studied by mass and NMR spectroscopies. Eur.J. Biochem. 224:89–96. doi:10.1111/j.1432-1033.1994.tb19998.x.
  • Peypoux, F., J. M. Bonmatin, and J. Wallach. 1999. Recent trends in the biochemistry of surfactin. Appl. Microbiol. Biotechnol. 51:553–63. doi:10.1007/s002530051432.
  • Rai, M., A. Yadav, and A. Gade. 2009. Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 27:76–83. doi:10.1016/j.biotechadv.2008.09.002.
  • Rajput, S., B. N. Kumar, S. Sarkar, S. Das, B. Azab, P. K. Santhekadur, S. K. Das, et al. 2013. Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer. PLoS One 18 (4):e61342. doi:10.1371/journal.pone.0061342.
  • Sabaté, D. C., and M. C. Audisio. 2013. Inhibitory activity of surfactin, produced by different Bacillus subtilis subsp. subtilis strains, against Listeria monocytogenes sensitive and bacteriocin-resistant strains. Microbiol. Res. 168:125–29. doi:10.1016/j.micres.2012.11.004.
  • Sajeesh, S., K. Bouchemal, V. Marsaud, C. Vauthier, and C. P. Sharma. 2010. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin. J. Controlled Release 147:377–84. doi:10.1016/j.jconrel.2010.08.007.
  • Samel., S. A., B. Wagner, M. A. Marahiel, and L. O. Essen. 2006. The thioesterase domain of the fengycin biosynthesis cluster: A structural base for the macrocyclization of a non-ribosomal lipopeptide. J. Mol. Biol. 359:876–89. doi:10.1016/j.jmb.2006.03.062.
  • Santos, V. S. V., C. F. Campos, E. O. de Campos Júnior, and B. B. Pereira. 2018. Acute ecotoxicity bioassay using Dendrocephalus brasiliensis: Alternative test species for monitoring of contaminants in tropical and subtropical freshwaters. Ecotoxicology 27:635–40. doi:10.1007/s10646-018-1951-3.
  • Santos, V. S. V., E. S. Caixeta, E. O. de Campos Júnior, and B. B. Pereira. 2017. Ecotoxicological effects of larvicide used in the control of Aedes aegypti on nontarget organisms: Redefining the use of pyriproxyfen. J. Toxicol. Environ. Health A 80:155–60. doi:10.1080/15287394.2016.1266721.
  • Schneider, A., T. Stachelhaus, and M. A. Marahiel. 1998. Targeted alteration of the substrate specificity of peptide synthetases by rational module swapping. Mol. Gen. Genet. 257:308–18. doi:10.1007/s004380050652.
  • Seydlová, G., and J. Svobodová. 2008. Review of surfactin chemical properties and the potential biomedical applications. Cent. Eur. J. Med. 3:123–33. doi:10.2478/s11536-008-0002-5.
  • Seydlová, G., R. Čabala, and J. Svobodová. 2011. Surfactin – Novel solutions for global issues. J. Biomed. Eng. Trends Res. Technol. InTech Open, 1st ed. doi:10.5772/13015.
  • Shao, C., L. Liu, H. Gang, S. Yang, and B. Mu. 2015. Structural diversity of the microbial surfactin derivatives from selective esterification approach. Int. J. Mol. Sci. 16:1855–72. doi:10.3390/ijms16011855.
  • Sibila, M. A., M. C. Garrido, J. A. Perales, and J. M. Quiroga. 2008. Ecotoxicity and biodegradability of an alkyl ethoxysulphate surfactant in coastal waters. Sci. Total Environ. 394:265–74. doi:10.1016/j.scitotenv.2008.01.043.
  • Singh, B. R., S. Dwivedi, A. A. Al-Khedhairy, and J. Musarrat. 2011. Synthesis of stable cadmium sulfide nanoparticles using surfactin produced by Bacillus amyloliquifaciens strain KSU-109. Colloids Surf. B Biointerfaces 85:207–13. doi:10.1016/j.colsurfb.2011.02.030.
  • Sivapathasekaran, C., P. Das, S. Mukherjee, J. Saravanamakumar, M. Mandal, and R. Sen. 2010. Marine bacterium derived lipopeptides: Characterization and cytotoxic activity against cancer cell lines. Int. J. Pept. Res. Ther. 16:215–22. doi:10.1007/s10989-010-9212-1.
  • Sobrino-Figueroa, A. 2018. Toxic effect of commercial detergents on organisms from different trophic levels. Environ. Sci. Pollut. Res. 25:13283–91. doi:10.1007/s11356-016-7861-0.
  • Stachelhaus, T., A. Schneider, and M. A. Marahiel. 1995. Rational design of peptide antibiotics by targeted replacement of bacterial and fungal domains. Science 269:69–72. doi:10.1126/science.7604280.
  • Stanley, N. R., and B. A. Lazazzera. 2004. Environmental signals and regulatory pathways that influence biofilm formation. Mol. Microbiol. 52:917–24. doi:10.1111/j.1365-2958.2004.04036.x.
  • Steller, S., A. Sokoll, C. Wilde, F. Bernhard, P. Franke, and J. Vater. 2004. Initiation of surfactin biosynthesis and the role of the Srfd-thioesterase protein. Biochemistry 43:11331–43. doi:10.1021/bi0493416.
  • Symmank, H., P. Franke, W. Saenger, and F. Bernhard. 2002. Modification of biologically active peptides: Production of a novel lipohexapeptide after engineering of Bacillus subtilis surfactin synthetase. Protein Eng. 15:913–21.
  • Tsukagoshi, N., G. Tamura, and K. Arima. 1970. A novel protoplast-bursting factor (surfactin) obtained from Bacillus subtilis IAM 1213: I. The effects of surfactin on Bacillus megaterium KM. Biochim. Biophys. Acta Biomembr. 196:204–10. doi:10.1016/0005-2736(70)90007-6.
  • Vollenbroich, D., M. Ozel, J. Vater, R. M. Kamp, and G. Pauli. 1997. Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Biologicals 25:289–97. doi:10.1006/biol.1997.0099.
  • Wang, C. L., T. B. Ng, F. Yuan, Z. K. Liu, and F. Liu. 2007. Induction of apoptosis in human leukemia K562 cells by cyclic lipopeptide from Bacillus subtilis natto T-2. Peptides 28:1344–50. doi:10.1016/j.peptides.2007.06.014.
  • Wang, Q., H. Yu, M. Wang, H. Yang, and Z. Shen. 2018. Enhanced biosynthesis and characterization of surfactin isoforms with engineered Bacillus subtilis through promoter replacement and Vitreoscilla hemoglobin co-expression. Process Biochem. 70:36–44. doi:10.1016/j.procbio.2018.04.003.
  • Watters, C., K. DeLeon, U. Trivedi, J. A. Griwold, M. Lyte, K. J. Hampel, M. J. Wargo, and K. P. Rumbaugh. 2013. Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Med. Microbiol. Immunol. 202:131–41. doi:10.1007/s00430-012-0277-7.
  • Whang, L. M., P. W. Liu, C. C. Ma, and S. S. Cheng. 2008. Application of biosurfactants, rhamnolipid, and surfactin, for enhanced biodegradation of diesel-contaminated water and soil. J. Hazard. Mater. 151:155–1563. doi:10.1016/j.jhazmat.2007.05.063.
  • Ying, G. G. 2006. Fate, behavior and effects of surfactants and their degradation products in the environment. Environ. Int. 32:417–31. doi:10.1016/j.envint.2005.07.004.
  • Youssef, N., D. R. Simpson, K. E. Duncan, M. J. McInerney, M. Folmsbee, T. Fincher, and R. M. Knapp. 2007. In situ biosurfactant production by Bacillus strains injected into a limestone petroleum reservoir. Appl. Environ. Microbiol. 73:1239–47. doi:10.1128/AEM.02264-06.
  • Yun, J. H., D. H. Cho, B. Lee, H. S. Kim, and Y. K. Chang. 2018. Application of biosurfactant from Bacillus subtilis C9 for controlling cladoceran grazers in algal cultivation systems. Sci. Rep. 8:5365. doi:10.1038/s41598-018-23535-8.
  • Zhang, L., Z. Gao, X. Zhao, and G. Qi. 2016. A natural lipopeptide of surfactin for oral delivery of insulin. Drug Deliv. 23:2084–93. doi:10.3109/10717544.2016.1153745.
  • Zhi, Y., Q. Wu, and Y. Xu. 2017. Genome and transcriptome analysis of surfactin biosynthesis in Bacillus amyloliquefaciens MT45. Sci. Rep. 7:40976. doi:10.1038/srep40976.
  • Zou, A., J. Liu, V. M. Garamus, Y. Yang, R. Willumeit, and B. Mu. 2010. Micellization activity of the natural lipopeptide [Glu1, Asp5] surfactin-c15 in aqueous solution. J. Phys. Chem. B 114:2712–18. doi:10.1021/jp908675s.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.